Case Study: myMeds—A multichannel support program for Type 2 Diabetes


The Challenge

  • Type 2 diabetes is a common, progressive, and long-term health condition that can place a significant burden on patient and healthcare resources if not managed
  • Oral hypoglycemic agents are the first-line pharmacological treatment to delay the need to start insulin therapy
  • Adherence to oral hypoglycemic agents can be as low as 36%
  • Targeting people's beliefs about their condition and medication can improve adherence to treatment

Our Behavior Change Approach

  • Health psychology theory and behavioral science principles were used to develop the program content
    • Focus groups were conducted with patients to develop insights into their understanding of diabetes and how they used their medications 
    • SMS messages, emails, and webpages were designed using validated behavior change techniques
    • Nurse calls were guided by behavior change principles and the nurses adopted a motivational interviewing approach to patient interactions

The Solution

The myMeds support program provided a highly-personalized, multichannel experience tailored to address key nonadherence risk factors for each patient in their 26-week program journey

Topics addressed included: 

  • Illness perceptions
  • Medication concerns
  • Strategies to help with remembering and organizing
  • Medication necessity
  • Diabetes distress

Patient beliefs were measured at enrollment to personalize their program journey, and determine intervention intensity (low, medium, high) 

The Impact

  • 20% increase in median prescriptions filled per year compared to matched control group

  • Significant increase in total number of prescriptions filled by myMeds patients (median = 6.0) compared to baseline (median = 5.0)

  • 81% NPS (recommend myMeds to others)

In addition to improvements in adherence, the myMeds program:

  • Improved disease and treatment understanding
  • Improved patients' ability to self-manage
  • Improved patients' health overall, as reported by 76% of patients

Learn more about our behavior change solutions.